SBIR and STTR Extension Act of 2022
Summary
The SBIR and STTR Extension Act of 2022 was signed into law on September 30, 2022, reauthorizing the SBIR and STTR programs through FY2025 and adding foreign risk management provisions. The bill does not appropriate new funds; it extends existing authorization. For retail investors, this maintains the status quo for federal R&D support to small businesses, providing continued but not expanded opportunities for small-cap tech, biotech, and defense contractors that rely on these awards.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The SBIR and STTR Extension Act of 2022 is already law—reauthorizing R&D programs for small businesses through FY2025.
- 2.No new funding is provided; the bill extends existing authorization and adds foreign risk management requirements.
- 3.For public companies, the impact is minimal and diffuse; most award recipients are private firms.
Market Implications
The market has already absorbed this 2022 law. There is no material earnings or revenue impact to report from this bill alone. Investors looking for federal R&D exposure should focus on broader appropriations cycles that determine actual funding levels for agencies running SBIR programs.
Full Analysis
What happened: The SBIR and STTR Extension Act of 2022 (S.4900) was introduced by Sen. Cardin (D-MD), passed both chambers with bipartisan support, and was signed into law on September 30, 2022. The bill reauthorizes the SBIR and STTR programs through fiscal year 2025 and introduces new due-diligence requirements regarding foreign affiliations and countries of concern. This is an authorization bill, not an appropriations bill—meaning it sets policy ceilings but does not allocate actual dollars. The SBIR and STTR programs operate through mandated set-asides of agency R&D budgets, and those percentages remain unchanged.
The money trail: No direct funding is provided in the bill. The programs themselves are funded through annual appropriations to participating federal agencies. The extension ensures that agencies continue to allocate the statutory percentages (3.2% for SBIR and 0.45% for STTR for most agencies) of extramural R&D budgets to competitive awards for small businesses. The new foreign risk provisions may reduce the pool of eligible applicants, potentially benefiting US-based companies with clear domestic ownership.
Structural winners and losers: The primary beneficiaries are small businesses that successfully compete for SBIR/STTR awards—many of which are private. Publicly traded companies that have historically received SBIR awards include small-cap innovators in defense technology (e.g., Kratos $KTOS), space (Rocket Lab $RKLB), satellite communications (AST SpaceMobile $ASTS), and quantum computing (IonQ $IONQ). However, the impact on any single public company is diluted because SBIR awards are typically modest (Phase I up to $250k, Phase II up to $1.5M) and represent a small fraction of revenue for even mid-cap firms. The bill's security provisions could disadvantage companies with substantial ties to countries of concern, but that effect is structural and gradual.
Timeline: The bill is already law. The reauthorization runs through FY2025, so the next expiration will require another extension or reauthorization. Investors should monitor whether Congress passes a new SBIR/STTR bill before the 2025 deadline.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
To amend the Small Business Act to require Federal agencies to provide enhanced debriefing materials to small business concerns for SBIR or STTR award denials, and for other purposes.
Small Business Innovation and Economic Security Act
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Restoring Reciprocity in Government Procurement
This Presidential Memorandum directs the Office of Management and Budget, the U.S. Trade Representative, and other federal agencies to identify and remove Canadian-origin items from federal civil procurement where possible, citing Canada's 'Buy Canadian' policies as discriminatory. It also requires agencies to be notified of domestic alternatives and mandates ongoing monitoring of Canada's procurement practices, with provisions for restoring access if Canada changes its policies.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Adjusting Certain Delegations Under the Defense Production Act
This proclamation amends Executive Order 13603 to share authority under the Defense Production Act for energy matters between the Secretary of the Interior and the Secretary of Energy, allowing each to act independently, and directs inter-agency dispute resolution via the National Energy Dominance Council and National Security Council, with coordination from the Department of War when national defense is implicated.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →